Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines

MLA

Bryan E. Strauss, et al. “Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines.” PLoS ONE, vol. 6, Nov. 2011, p. e27707. EBSCOhost, https://doi.org/10.1371/journal.pone.0027707.

APA

Bryan E. Strauss, Djordje Atanackovic, Erico T. Costa, Gisele W. B. Colleoni, Anamaria A. Camargo, Otavia L. Caballero, Valeria C.C. Andrade, Juliana C. Gregorio, Cibele Masotti, & Fabricio de Carvalho. (2011). Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines. PLoS ONE, 6, e27707. https://doi.org/10.1371/journal.pone.0027707

Chicago

Bryan E. Strauss, Djordje Atanackovic, Erico T. Costa, Gisele W. B. Colleoni, Anamaria A. Camargo, Otavia L. Caballero, Valeria C.C. Andrade, Juliana C. Gregorio, Cibele Masotti, and Fabricio de Carvalho. 2011. “Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines.” PLoS ONE 6 (November): e27707. doi:10.1371/journal.pone.0027707.